EUCTR2020-002940-22-IT进行中（未招募）1 期
EFFECTS OF THE GLP-1 RECEPTOR AGONIST LIRAGLUTIDE ON LOWER LIMB PERFUSION IN PEOPLE WITH TYPE 2 DIABETES AND PERIPHERAL ARTERY DISEASE: A RANDOMIZED CONTROLLED TRIAL - STARDUST
A.O.U. Università degli Studi della Campania Luigi Vanvitelli0 个研究点目标入组 50 人开始时间: 2021年5月24日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients with type 2 diabetes, peripheral artery disease with transcutaneous oxygen tension on lower limbs between 49 and 30 mmHg and with:
- •-HbA1c 6.5% - 8%.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 50
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 50
排除标准
- •Type 1 diabetes or diabetes secondary to specific causes
- •Previous treatment (within the last 3 months) with a GLP-1RA or a DPP-4 inhibitor
- •Contraindications to the use of GLP-1RA (pancreatitis)
- •Pregnancy or pregnancy scheduled during the study period
- •Planned vascular revascularization
- •GFR <15 ml/min
- •History of cancer or anti-neoplastic therapy in the 5 years prior to randomization
- •Current therapy with oral, topical or systemic glucocorticoids, or with atypical antipsychotics.
研究者
相似试验
进行中（未招募）
1 期
Effect of the GLP-1 analogue liraglutide on intragastric pressure and satiation during nutrient drink infusion.healthy volunteersno medical conditiondrugs will be studied because they are known to influence gastric motility.EUCTR2010-023226-20-BEKULeuven
进行中（未招募）
不适用
Assessing the efficacy and safety of the GLP1-agonist liraglutide in patients who developed diabetes as a consequence of the use of anti-psychotic drugsEUCTR2013-005395-18-NLniversity Medical Center Utrecht
撤回
4 期
Effects of GLP1 agonist liraglutide in patients with antipsychotic-drugs-associated diabetes mellitus10018424Diabetes MellitusNL-OMON40321Interne geneeskunde50
招募中
不适用
Comparing effects of a long acting GLP-1 receptor agonist liraglutide with a short acting GLP-1 receptor agonist lixisenatide on diabetic cardiac autonomic neuropathy and glycemic variability evaluated by power spectral analysis of 24-hr heart rate and continuous glucose monitoring.Type 2 diabetesJPRN-UMIN000017144Department of Endocrinology and Metabolism, Dokkyo Medical University30
进行中（未招募）
不适用
ELAD StudyEUCTR2013-000962-13-GBImperial College London